-
LONG-TERM CAREGIVING FOR SCHIZOPHRENIA IN CHINA: A QUALITATIVE STUDY OF BURDEN DIMENSIONS AND GAPS IN EXISTING ASSESSMENT
Aug 11, 2026, 17:16 PM -
DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS: A CASE STUDY OF VENTRAL HERNIAS IN ENGLAND AND THE ROLE OF TARGETED IMPLEMENTATION
Aug 11, 2026, 17:16 PM -
DAGLIVE: AN AI-AUGMENTED INTERACTIVE APPLICATION FOR LIVING CAUSAL DIAGRAMS
Aug 11, 2026, 17:16 PM -
A BAYESIAN FRAMEWORK FOR LIFE CYCLE COST EFFECTIVENESS OF ATMPS: AN ONASEMNOGENE ABEPARVOVEC CASE STUDY
Aug 11, 2026, 17:16 PM -
BUDGET-IMPACT ANALYSIS OF TIVIDENOFUSP ALFA; A BLOOD-BRAIN BARRIER-CROSSING ENZYME REPLACEMENT THERAPY FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II IN PEDIATRIC PATIENTS WITH NEUROLOGIC SYMPTOMS
Aug 11, 2026, 17:16 PM -
HEALTH TECHNOLOGY ASSESSMENT RELEVANT VALIDATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN FIRST-LINE METASTATIC TRIPLE-NEGATIVE BREAST CANCER: A BAYESIAN META-ANALYTIC FRAMEWORK
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPLICIT INCLUSION OF INFORMAL CARER SPILLOVERS IN HEALTH STATE VALUATION USING DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF THE COMPLICATION MODEL FOR OBESITY AND OVERWEIGHT (COMET): A PATIENT-LEVEL STOCHASTIC MICROSIMULATION MODEL FOR OBESITY-RELATED COMPLICATIONS AND MORTALITY
Aug 11, 2026, 17:16 PM -
LEARNING WHILE USING: EVIDENCE EXPECTATIONS UNDER NICE'S REFORMED HEALTHTECH PROGRAM
Aug 11, 2026, 17:16 PM -
BIMEKIZUMAB IMPACT ON PAIN AND QUALITY OF LIFE STRATIFIED BY IHS4 LEVELS IN PATIENTS WITH HIDRADENITIS SUPPURATIVA: 3-YEAR RESULTS FROM BE HEARD EXT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A STUDY FROM A JORDANIAN PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COST SAVINGS ASSOCIATED WITH THE INTRODUCTION OF SUBCUTANEOUS VERSUS INTRAVENOUS PEMBROLIZUMAB IN GREECE
Aug 11, 2026, 17:16 PM -
HEALTH LITERACY, SHARED DECISION-MAKING AND REASONS FOR LOW MEDICATION ADHERENCE: INSIGHTS FROM A MIXED-METHODS STUDY IN NORWAY
Aug 11, 2026, 17:16 PM -
ADVANCING REIMBURSEMENT CHALLENGES FOR ADVANCED THERAPY MEDICINAL PRODUCTS: A ROOT CAUSE ANALYSIS
Aug 11, 2026, 17:16 PM -
CLOSING GAPS IN REAL-WORLD EVIDENCE: UNLOCKING CLINICAL VALUE FROM UNSTRUCTURED EHR NOTES
Aug 11, 2026, 17:16 PM -
IMPACT OF US MOST-FAVOURED NATION (MFN) PRICING POLICY ON PCPA NEGOTIATION ACTIVITY IN CANADA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF SPINAL MUSCULAR ATROPHY IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
ANTIFUNGAL STEWARDSHIP IN A CENTRAL HOSPITAL: GUIDELINE ADHERENCE, CONSUMPTION AND 30-DAY MORTALITY IN 2025
Aug 11, 2026, 17:16 PM -
FAMILY SPILLOVER EFFECTS IN PHARMACOECONOMIC EVALUATION: A SYSTEMATIC REVIEW OF INTERNATIONAL GUIDELINES
Aug 11, 2026, 17:16 PM -
HOW DO HTA AGENCIES EVALUATE EXTERNAL CONTROL ARM EVIDENCE? FINDINGS FROM CAR-T APPRAISALS ACROSS FIVE JURISDICTIONS
Aug 11, 2026, 17:16 PM
